CN107412409A - The new medicine use of shiny-leaved yellowhorn woody part and blade - Google Patents
The new medicine use of shiny-leaved yellowhorn woody part and blade Download PDFInfo
- Publication number
- CN107412409A CN107412409A CN201710645435.5A CN201710645435A CN107412409A CN 107412409 A CN107412409 A CN 107412409A CN 201710645435 A CN201710645435 A CN 201710645435A CN 107412409 A CN107412409 A CN 107412409A
- Authority
- CN
- China
- Prior art keywords
- shiny
- medicine
- leaved yellowhorn
- blade
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 244000248162 Xanthoceras sorbifolium Species 0.000 title claims abstract description 35
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims abstract description 32
- 201000005569 Gout Diseases 0.000 claims abstract description 23
- 201000010099 disease Diseases 0.000 claims abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 18
- 230000002503 metabolic effect Effects 0.000 claims abstract description 12
- 241000238631 Hexapoda Species 0.000 claims abstract description 4
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 4
- 239000000575 pesticide Substances 0.000 claims abstract description 4
- 235000013402 health food Nutrition 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 5
- 230000007613 environmental effect Effects 0.000 claims description 3
- 230000011218 segmentation Effects 0.000 claims description 3
- 235000014347 soups Nutrition 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 9
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 12
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 11
- 229940116269 uric acid Drugs 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 8
- 235000013305 food Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001503 joint Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000026816 acute arthritis Diseases 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000408907 Xanthoceras Species 0.000 description 1
- 235000009240 Xanthoceras sorbifolium Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to drug field, more particularly to the purposes of shiny-leaved yellowhorn woody part and blade in preparing treatment gout or preventing the medicine of purine metabolic disturbance.Comprise the following steps：A, gather fresh clean, in green, without go mouldy, insect pest, residues of pesticides shiny-leaved yellowhorn woody part and leaf portion；B, sliced, frying, it is made after drying and can extracts or decoction or electuary and traditional Chinese medicine and Mongolia Medicine medicinal material used in patent medicine.Beneficial effect：The present invention is in gout, clinical verification is given with shiny-leaved yellowhorn medicine materical crude slice with the patient of oral colchicin and other purine piece in the form of brewing and contrasted in the crowd of purine metabolic disturbance diseases, wherein 95% patient symptom mitigates or disappeared, and does not find toxic side effect, and effect is unexpectedly more obvious.
Description
Technical field
The present invention relates to drug field, more particularly to traditional Chinese medicine and Mongolia Medicine shiny-leaved yellowhorn woody part and blade to prepare treatment pain
Medicinal usage in wind or prevention purine metabolic disturbance diseases.
Background technology
Shiny-leaved yellowhorn (Xanthoceras sorbifoliaBunge.), it is that the distinctive woody oleiferous plants in China and Medicinal are planted
Thing, according to《National Chinese herbal medicine compilation》、《Chinese book on Chinese herbal medicine》Found etc. the medicine pharmacology about shiny-leaved yellowhorn and the scope of clinical practice, its
All it is used as medicine with the woody part and blade of shiny-leaved yellowhorn, for oral administration or external application.Major function：Dispelling wind and eliminating dampness；Swelling and pain relieving.Main beriberoid pyretic arthralgia；
Arthralgia and myalgia.The entitled hila of anaesthetic is gloomy to be stepped on, and energy wind-damp dispelling, swelling and pain relieving, holds back dry yellow water, is clinically used for treating rheumatic pass
Section is scorching, the disease such as heat, skin rheumatism in rheumatism.But at present in addition to finding its above effect purposes, in Other diseases especially
It is that medicinal application in gout and purine metabolic disturbance diseases has no and realizes direction.The traditional Chinese medical science think goat more by diseases caused by external factors it is damp and hot it
Evil or chill the strongly fragrant longization heat of heresy, or internal injury kidney deficiency and liver or bi Zheng are with the passing of time, blood stasis phlegm hinders and caused.Though belong to rheumatism, its pain
Acutely, recurrent exerbation, it is touching not to be cured, so that joint deformity, and have multiple complications, therefore again not in general rheumatism.Doctor trained in Western medicine thinks
Gout be largely be deposited between joint by uric acid crystal thing caused by.Uric acid is a kind of inevitable metabolite in human body.Just
In the case of often, uric acid can be delivered to kidney by blood and be excreted with urine.The excessive uric acid of body, can form crystal, deposit
Intra-articular, cause severe pain.When human body serum Uric Acid Concentration is too high, uric acid i.e. be deposited in the form of sodium salt joint, soft tissue,
In cartilage and kidney, cause the foreign matter inflammation of tissue.Often occur in foot articulationes metatarsophalangeae, thumb joint or heel, instep, ankle
Joint or other joints, affected joints are made to occur shouting pain, the heating of short time inner skin is simultaneously congested until arthroncus, 24 hours
Peak, sharp ache are inside can reach, the lighter free regression, severe one can will continue more days or a few weeks, most gouts within a few hours
Will recurrence.As treated not in time, then chronic, chronicity disease is easily formed, and permanent lesion is caused to joint, not only influenceed
Normal life, the working and learning of patient, more seriously endanger the health of patient.And lithate is the one kind found in urine
White, tasteless crystal, it is practically insoluble in water, ethanol and ether, but is dissolved in basic salt.The medicine of existing treatment gout
Such as：Benzbromarone (skin graft immediately), its main mechanism are the great absorptions for resisting renal tubule to uric acid, increase renal tubule pair
The excretion of uric acid；Allopurinol, resist the generation of uric acid；This kind of medicine is often accompanied by gastrointestinal reaction diarrhoea, upset,gastro-intestinal, skin
Rash, leucocyte and writes platelet reduction, liver function damage, the toxicity, side effect such as toxicity epithelium necrosis, moreover, being once discontinued, can answer again
Hair, it is impossible to effect a radical cure.Compound nerve capsule, although redness and swelling of joints, heat pain, joint stuffiness caused by gout caused by hot stasis blocking being treated
Deng disease, but sour and astringent and purine-containing the food of necessary fasting raw food during medication, such as seafood, bean product and other nutriments
Deng, easily cause body malnutrition, resistance, immunity degradation and cause the adverse consequences such as Other diseases.Therefore the disease
Prevention and treatment also become the problem that current medical field is not captured.
It is a discovery of the invention that contain saponin of Lignum Xanthoceratis (20.3mg/100g) in fresh and tender shiny-leaved yellowhorn trees portion and blade respectively
Triterpenoid saponin (30.3mg/100g) flavones (29.76mg/100g) polyphenol (29.6GAEmg/100g) isoreactivity drug ingedient and
Calcium (489.4mg/100g) iron (21.3mg/100g) potassium (1820.9mg/100g), zinc (3.9mg/100g) magnesium (78.2mg/
The trace element such as 100g).The ingenious combination of these active pharmaceutical ingredients and trace element and its content ratio contained by it is not
But it can effectively prevent the repetition of human body protein nutrition from absorbing, increase the wriggling and number of micturitions of bladder, so as to improve kidney
Purine metabolism function, the uric acid content in blood is reduced, prevent acid sodium-salt from crystallizing to be formed, promote the discharge of blood uric acid, alleviate disease
People's pain, progressively degrade focus acid sodium-salt crystalline material, with this reach radical cure gout and caused by purine metabolic disturbance its
The purpose of his disease.The present invention verifies that there is the generation for suppressing high lithemia sodium salt crystal to make in shiny-leaved yellowhorn branches and leaves portion by clinic application
With, there is good preventive and therapeutic action to gout or purine metabolic disturbance diseases, it is fast for preparing treatment gout and prevention
The medicine or Food and hygienical food of purine metabolic disturbance diseases, and it is without any side effects to human body.Shiny-leaved yellowhorn woody part and leaf
The new medicine use of piece.
The purpose of invention：In order to provide a kind of medicine and emphasis using the effect of the medicine of shiny-leaved yellowhorn woody part and blade.
In order to reach as above purpose, the present invention adopts the following technical scheme that：
Scheme one：
The purposes of shiny-leaved yellowhorn woody part and blade in the medicine or health food for preparing treatment gout.
Scheme two：
The purposes of shiny-leaved yellowhorn woody part and blade in the medicine or health food for preparing prevention purine metabolic disturbance diseases.
Scheme three：
Shiny-leaved yellowhorn woody part and blade are used to treat the use in gout and urarthritis or health food in prescription
On the way.
Scheme four：
Shiny-leaved yellowhorn woody part blade is used to prevent in purine metabolic disturbance diseases or Food and hygienical food in prescription
Purposes
Scheme five：Treat the medicine of gout, it is characterised in that comprise the following steps：
A gather it is fresh and tender, clean, without go mouldy, the woody part and blade of the shiny-leaved yellowhorn of insect pest and residues of pesticides；
B is sliced, system, dry after be made and can extract or decoct soup or brew tablet used.
Further technical scheme of the invention is, the frying refer to by after the fresh and tender sliced segmentation of shiny-leaved yellowhorn woody part with
After fresh leaves are according to the ratio mixing that wooden leaf ratio is 3: 7, it is placed in environment temperature frying half an hour under conditions of 90 DEG C, dries
Refer to the above-mentioned article after frying is placed in dehydration system under 50--75 DEG C of environmental condition and done to moisture content to be not more than 7%
Dry product.
Using the present invention of as above technical scheme, had the advantages that relative to prior art：The present invention is fast in gout
Used in the crowd of purine metabolic disturbance diseases fresh and tender shiny-leaved yellowhorn woody part and blade made of medicine materical crude slice in the form of brewing with it is oral
The patient of colchicin and other purine tablet gives clinical verification and contrasted, wherein：Gout and gouty are suffered to part
The directly oral colchicin of the patient of acute arthritis and other purine piece, except the symptom to some patients have some mitigations with
Outside, but therapeutic effect and unobvious.The present invention see and treat patients altogether since two thousand and ten gout and gouty acute arthritis patient it is near
Thousand and all orally found for patient in the form of shinyleaf yellowhorn fruit shell medicine materical crude slice brews, the curative competence of clinical effectiveness of the invention
More than 95%, and toxic side effect is not found, effect is unexpectedly more obvious.
Embodiment
Embodiments of the invention are illustrated below, embodiment is not construed as limiting the invention：
Shiny-leaved yellowhorn woody part and blade are preparing the purposes in treating and preventing gout medicine or health food.
Shiny-leaved yellowhorn woody part and blade are in treatment and prevention purine metabolic disturbance diseases medicine or health food is prepared
Purposes.
Treat the medicine of gout, it is characterised in that comprise the following steps：
A gather it is fresh and tender, clean, without go mouldy, the woody part and blade of the shiny-leaved yellowhorn of insect pest and residues of pesticides；
B is sliced, system, dry after be made and can extract or decoct soup or brew tablet used.
Further technical scheme of the invention is, the frying refer to by after the fresh and tender sliced segmentation of shiny-leaved yellowhorn woody part with
After fresh leaves are according to the ratio mixing that wooden leaf ratio is 3: 7, it is placed in environment temperature frying half an hour under conditions of 90 DEG C, dries
Refer to the above-mentioned article after frying is placed in dehydration system under 50--75 DEG C of environmental condition and done to moisture content to be not more than 7%
Dry product.
The substantive distinguishing features of the present invention can be found out by following：Seen and treated patients altogether since 20010 gout and gout of the invention
The arthritic patient nearly thousand of impatient property and medicine materical crude slice made of fresh and tender shiny-leaved yellowhorn woody part and blade is all used in the form of brewing
Orally found for patient, the curative competence of clinical effectiveness of the invention does not find toxic side effect more than 95%, and effect is unexpectedly
It is more obvious.
Clinical experiment report (part)
General principle, principal character and the advantages of the present invention of the present invention has been shown and described above.The technology of this area
Personnel should be recognized that the present invention is not limited to the above embodiments, simply illustrate this hair described in above-described embodiment and specification
Bright principle, without departing from the spirit and scope of the present invention, various changes and modifications of the present invention are possible, these changes
Both fallen within improving in claimed scope.
It is related to the bibliography of the present invention：
1st, the Primary Study of shiny-leaved yellowhorn study on chemical compositions of leaves《Chinese Wild plant》03 phase in 1989.Author：Zhu Dan, Wang Hong
Bucket；
2nd, shiny-leaved yellowhorn study on chemical compositions of leaves is studied《Chinese patent drug》10 phases in 2010.Author：Ma Yangmin, king wear；
3rd, the chemical constitution study of anaesthetic wood of shiny-leaved yellowhorn《Medical Colleges of the Inner Mongol's master's research paper》2008.11.01.Author：
Wang Hongwei.；
4th, wood of shiny-leaved yellowhorn chemical constitution study《Beijing University of Chinese Medicine's journal》12 phases in 2008.Author：Dong Yu, Wang Hongwei
Deng；
5th, the edible and medical value of shiny-leaved yellowhorn《Chinese Medicine guide》2006. the 10th phases.Author：Wang Lihua.
Claims (4)
1. shiny-leaved yellowhorn woody part and blade are in treatment and prevention gout and urarthritis medicine or health food is prepared
Purposes.
2. shiny-leaved yellowhorn woody part and blade position are preparing the use in treating and preventing purine metabolic disturbance diseases medicine or health food
On the way.
3. treat the medicine of gout, it is characterised in that comprise the following steps：
A gather it is fresh and tender, clean, without go mouldy, the woody part and blade of the shiny-leaved yellowhorn tree of insect pest and residues of pesticides；
B is sliced, frying, dry after be made can extract decoct soup or brew and patent medicine used in tablet.
4. the medicine for the treatment of gout as claimed in claim 3, it is characterised in that the frying refers to fresh and tender shiny-leaved yellowhorn wood
After being mixed after the sliced segmentation in portion with fresh leaves according to the ratio that wooden leaf ratio is 3: 7, condition of the environment temperature at 90 DEG C is placed in
Lower frying half an hour, dry refer to by the above-mentioned article after frying be placed under 50--75 DEG C of environmental condition be dehydrated system do to
Moisture content is not more than 7% dry product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710645435.5A CN107412409A (en) | 2017-07-24 | 2017-07-24 | The new medicine use of shiny-leaved yellowhorn woody part and blade |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710645435.5A CN107412409A (en) | 2017-07-24 | 2017-07-24 | The new medicine use of shiny-leaved yellowhorn woody part and blade |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107412409A true CN107412409A (en) | 2017-12-01 |
Family
ID=60436376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710645435.5A Pending CN107412409A (en) | 2017-07-24 | 2017-07-24 | The new medicine use of shiny-leaved yellowhorn woody part and blade |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107412409A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112042845A (en) * | 2020-10-15 | 2020-12-08 | 松林 | Xanthoceras sorbifolia leaf beverage and preparation method thereof |
| CN116870068A (en) * | 2023-08-07 | 2023-10-13 | 内蒙古科技大学包头医学院 | Application of shinyleaf yellowhorn leaf in preparation of medicine for preventing and treating hyperuricemia nephropathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103988957A (en) * | 2014-05-12 | 2014-08-20 | 师海全 | Health care tea prepared by using narrow leaves and tender branches of wood of shinyleaf yellowhorn |
| CN106668276A (en) * | 2015-11-05 | 2017-05-17 | 甘肃长瑞文冠果产业发展有限公司 | Tea and health food for treating gout and medical application thereof |
-
2017
- 2017-07-24 CN CN201710645435.5A patent/CN107412409A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103988957A (en) * | 2014-05-12 | 2014-08-20 | 师海全 | Health care tea prepared by using narrow leaves and tender branches of wood of shinyleaf yellowhorn |
| CN106668276A (en) * | 2015-11-05 | 2017-05-17 | 甘肃长瑞文冠果产业发展有限公司 | Tea and health food for treating gout and medical application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 许良等: "微波消解-电感耦合等离子体原子发射光谱(ICP-AES)法测定蒙药材文冠木中16种元素", 《中国无机分析化学》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112042845A (en) * | 2020-10-15 | 2020-12-08 | 松林 | Xanthoceras sorbifolia leaf beverage and preparation method thereof |
| CN116870068A (en) * | 2023-08-07 | 2023-10-13 | 内蒙古科技大学包头医学院 | Application of shinyleaf yellowhorn leaf in preparation of medicine for preventing and treating hyperuricemia nephropathy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105166544A (en) | Pig mixed feed and preparation method thereof | |
| CN107412409A (en) | The new medicine use of shiny-leaved yellowhorn woody part and blade | |
| CN104524522B (en) | A kind of compound ointment for treating pernio | |
| CN106234803A (en) | For treating the feedstuff of piglet pujos blancos | |
| CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
| CN105596587A (en) | Composition for relieving swelling and pain | |
| CN102988869B (en) | Chinese medicinal composition for treating intestinal obstruction | |
| CN106668276A (en) | Tea and health food for treating gout and medical application thereof | |
| CN108392600A (en) | A kind of Chinese medicinal formulae for treating apoplexy | |
| CN103948899B (en) | A kind of Tibetan medicine for the treatment of atrophic gastritis | |
| CN106975036A (en) | A kind of compound deacidification tea and preparation method thereof | |
| CN102198261A (en) | Chinese medicinal preparation for treating elder chronic colitis and preparation method thereof | |
| CN105596978A (en) | Drug for treating nerve injury and preparation method thereof | |
| CN104958520A (en) | Traditional Chinese medicine for treating osteoarthritis | |
| CN105106533B (en) | A kind of Chinese medicine composition for treating gestational period gall stone | |
| CN105079601A (en) | Liquor for dispelling wind and dehumidifying | |
| CN103768317A (en) | Traditional Chinese medicinal composition for treating biliary tract ascariasis | |
| CN103893732B (en) | A kind of Tibetan medicine treating chronic gastritis | |
| CN103432418B (en) | Chinese medicine composition of a kind of gout pain relieving and its production and use | |
| CN103520653B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN106177101A (en) | The new application at middle mongolian medicine shinyleaf yellowhorn fruit shell position | |
| CN107753568A (en) | A kind of Chinese medicine composition for being used to prevent and treat poultry proventriculitis, ventriculitis | |
| CN104435938B (en) | Treat pharmaceutical composition and its application of eczema | |
| CN104825877A (en) | Traditional Chinese medicine for treating liver and gallbladder diseases | |
| CN104587366B (en) | A kind of Chinese medicine composition for treating caused by hepatic stagnation qi stagnation stomachache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171201 |